Wedbush initiated coverage of Artiva Biotherapeutics with an Outperform rating and $18 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ARTV: JMP Securities healthcare analysts hold an analyst/industry conference call Disclaimer & DisclosureReport an Issue
